172
Participants
Start Date
June 30, 2020
Primary Completion Date
December 8, 2021
Study Completion Date
February 24, 2025
Tiragolumab
Tiragolumab at a fixed dose of 600 milligrams (mg) will be administered by intravenous (IV) infusion every 3 weeks (Q3W) on Day 1 of each 21-day cycle.
Atezolizumab
Atezolizumab at a fixed dose of 1200 mg will be administered by IV infusion Q3W on Day 1 of each 21-day cycle.
National Taiwan University Hospital, Taipei
Chang Gung Medical Foundation, Linkou Branch, Taoyuan
Mater Misericordiae Limited, South Brisbane
Clinica CIMCA, San José
ICIMED Instituto de Investigación en Ciencias Médicas, San José
Taipei Veterans General Hospital, Taipei
Institut Paoli Calmettes, Marseille
Complejo Hospitalario Universitario A Coruña (CHUAC), A Coruña
Istituto Europeo Di Oncologia, Milan
Hospital Universitario 12 de Octubre, Madrid
Hospital Universitario La Paz, Madrid
Augusta University, Augusta
Centre Régional de Lutte Contre Le Cancer Val D'aurelle Paul Lamarque, Montpellier
Taichung Veterans General Hospital, Taichung
Keimyung University Dongsan Hospital, Daegu
ICO - Site René Gauducheau, Saint-Herblain
Maharaj Nakorn Chiang Mai Hospital, Muang
Christus Muguerza Clinica Vidriera, Monterrey
Centre Leon Berard, Lyon
Istituto Tumori Napoli, Napoli
Arizona Oncology Associates, Phoenix
Kaiser Permanente - Irvine, Irvine
Gustave Roussy, Villejuif
Oncology Associates of Oregon, P.C, Eugene
MEDSI Clinical Hospital on Pyatnitsky Highway, Moscow
Volgograd Regional Clinical Oncology Dispensary, Volgograd
Republican Clinical Oncology Dispensary of Ministry of Healthcare of Tatarstan Republic, Kazan'
Chelyabisnk regional clinical center for oncology and nuclear medicine, Chelyabinsk
Tomsk scientific research institute of oncology SO RAMN, PAD, Tomsk
Hospital Sao Rafael - HSR, Salvador
Hospital Araujo Jorge, Goiânia
Hospital de Caridade de Ijui, Ijuí
Hospital Nossa Senhora da Conceicao, Porto Alegre
Clinica de Pesquisa e Centro de Estudos em Oncologia Ginecologica e Mamaria Ltda, São Paulo
Royal Victoria Regional Health Centre, Barrie
London Regional Cancer Centre, London
Princess Margaret Cancer Center, Toronto
Jewish General Hospital, Montreal
McGill University Health Centre - Glen Site, Montreal
Policlinico Universitario Agostino Gemelli, Rome
Centro Oncológico de Panamá, Panama City
The Panama Clinic, Panama City
Clinica Ricardo Palma, San Isidro
Szpital Morski im.PCK, Gdynia
Narodowy Inst.Onkol.im.Sklodowskiej-Curie Panstw.Inst.Bad Gliwice, Gliwice
Wielkopolskie Centrum Onkologii im. M. Sklodowskiej-Curie, Poznan
Narodowy Instytut Onkologii im. M.Sklodowskiej-Curie, Warsaw
Korea Cancer Center Hospital of Korea Institute of Radiological and Medical Sciences, Seoul
Seoul National University Hospital, Seoul
Severance Hospital, Yonsei University Health System, Seoul
Asan Medical Center, Seoul
Gangnam Severance Hospital, Seoul
Samsung Medical Center, Seoul
Mackay Memorial Hospital, Taipei
University College London Hospital, London
Sarah Cannon Research Institute, London
Hoffmann-La Roche
INDUSTRY